Lataa...
Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis
BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common functional gastroenterological diseases, affecting 11.2 % of people worldwide. Previous studies have shown that probiotic treatment may benefit IBS patients. However, the effect of probiotics and the appropriate type, dose, and tre...
Tallennettuna:
| Julkaisussa: | BMC Gastroenterol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907258/ https://ncbi.nlm.nih.gov/pubmed/27296254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-016-0470-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|